Filing Flows

Filing Flows › RxSight (RXST) › Next earnings date

RxSight (RXST) earnings: missed the estimate

RxSight (RXST) reported on Nov 3, 2026 and missed the EPS estimate: −$0.21 against −$0.19 (-11.5%). Revenue was $24.6M for Q3 2026, -19% year over year. It beat the EPS estimate in 60% of the quarters on record.

Last result−11.5% vs estimate
Beat rate60%

The last report

RxSight reported revenue of $24.6M for the third quarter 2026 (-19% Y/Y), net loss $16.2M: Rxlal $22.8M, Service Warranty Service Contracts and Accessories $1.4M, LDD $427K. How it makes money → · Every quarter →

RxSight: EPS against the estimate, last 5 reportsRxSight: EPS against the estimate, last 5 reportsEstimateReported−$0.26−$0.04Nov 25−$0.20−$0.03Feb 26−$0.15−$0.19May 26−$0.19−$0.11Aug 26−$0.19−$0.21Nov 26
Latest (Nov 26): Estimate −$0.19, Reported −$0.21.
RXST: the stock's move on each reportRXST: the stock's move on each reportAug 5, 2026-2.7%May 6, 2026-20.1%Feb 25, 2026-11.4%Nov 5, 2025-4.3%

RxSight's latest quarter

RxSight, Q3 2026: revenue $24.6M (-19% year over year), operating margin -75.3%, net loss $16.2M, operating cash flow $45.2M. The chart follows the revenue to costs, profit and cash.

Questions

Did RxSight beat earnings?

RxSight (RXST) reported on Nov 3, 2026 and missed the EPS estimate: −$0.21 against −$0.19 (-11.5%).

When does RXST report earnings?

The next date is not set yet.

Does RxSight usually beat earnings?

It beat the consensus EPS estimate in 60% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.